nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ADRB2—chronic obstructive pulmonary disease	0.35	1	CbGaD
Metoprolol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0852	0.158	CbGbCtD
Metoprolol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0839	0.156	CbGbCtD
Metoprolol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0646	0.12	CbGbCtD
Metoprolol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0646	0.12	CbGbCtD
Metoprolol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0636	0.118	CbGbCtD
Metoprolol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0636	0.118	CbGbCtD
Metoprolol—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0213	0.0395	CbGbCtD
Metoprolol—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0213	0.0395	CbGbCtD
Metoprolol—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0162	0.0301	CbGbCtD
Metoprolol—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0162	0.0301	CbGbCtD
Metoprolol—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0144	0.0268	CbGbCtD
Metoprolol—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00895	0.0166	CbGbCtD
Metoprolol—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00764	0.0142	CbGbCtD
Metoprolol—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00722	0.0134	CbGbCtD
Metoprolol—Metipranolol—ADRB2—chronic obstructive pulmonary disease	0.000475	0.109	CrCbGaD
Metoprolol—Sotalol—ADRB2—chronic obstructive pulmonary disease	0.000423	0.0968	CrCbGaD
Metoprolol—Esmolol—ADRB2—chronic obstructive pulmonary disease	0.000377	0.0863	CrCbGaD
Metoprolol—Bevantolol—ADRB2—chronic obstructive pulmonary disease	0.000373	0.0853	CrCbGaD
Metoprolol—Betaxolol—ADRB2—chronic obstructive pulmonary disease	0.000332	0.076	CrCbGaD
Metoprolol—Atenolol—ADRB2—chronic obstructive pulmonary disease	0.000329	0.0753	CrCbGaD
Metoprolol—Bisoprolol—ADRB2—chronic obstructive pulmonary disease	0.000321	0.0734	CrCbGaD
Metoprolol—Acebutolol—ADRB2—chronic obstructive pulmonary disease	0.000304	0.0695	CrCbGaD
Metoprolol—Oxprenolol—ADRB2—chronic obstructive pulmonary disease	0.000302	0.069	CrCbGaD
Metoprolol—Alprenolol—ADRB2—chronic obstructive pulmonary disease	0.000276	0.0631	CrCbGaD
Metoprolol—Betaxolol—CYP1A2—chronic obstructive pulmonary disease	0.000275	0.0628	CrCbGaD
Metoprolol—Pindolol—ADRB2—chronic obstructive pulmonary disease	0.000237	0.0543	CrCbGaD
Metoprolol—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000194	0.00197	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000193	0.00196	CcSEcCtD
Metoprolol—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00194	CcSEcCtD
Metoprolol—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000191	0.00194	CcSEcCtD
Metoprolol—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00194	CcSEcCtD
Metoprolol—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00194	CcSEcCtD
Metoprolol—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.00192	CcSEcCtD
Metoprolol—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.00191	CcSEcCtD
Metoprolol—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000188	0.00191	CcSEcCtD
Metoprolol—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00191	CcSEcCtD
Metoprolol—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00191	CcSEcCtD
Metoprolol—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00191	CcSEcCtD
Metoprolol—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00191	CcSEcCtD
Metoprolol—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00191	CcSEcCtD
Metoprolol—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00191	CcSEcCtD
Metoprolol—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00191	CcSEcCtD
Metoprolol—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.0019	CcSEcCtD
Metoprolol—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.0019	CcSEcCtD
Metoprolol—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.0019	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.0019	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000187	0.0019	CcSEcCtD
Metoprolol—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00187	CcSEcCtD
Metoprolol—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00187	CcSEcCtD
Metoprolol—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00187	CcSEcCtD
Metoprolol—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00187	CcSEcCtD
Metoprolol—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00187	CcSEcCtD
Metoprolol—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00186	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00186	CcSEcCtD
Metoprolol—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000183	0.00186	CcSEcCtD
Metoprolol—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.00183	CcSEcCtD
Metoprolol—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00018	0.00183	CcSEcCtD
Metoprolol—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00183	CcSEcCtD
Metoprolol—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00181	CcSEcCtD
Metoprolol—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00181	CcSEcCtD
Metoprolol—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000177	0.0018	CcSEcCtD
Metoprolol—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.0018	CcSEcCtD
Metoprolol—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.0018	CcSEcCtD
Metoprolol—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000177	0.0018	CcSEcCtD
Metoprolol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000177	0.0018	CcSEcCtD
Metoprolol—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000177	0.0018	CcSEcCtD
Metoprolol—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00179	CcSEcCtD
Metoprolol—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00179	CcSEcCtD
Metoprolol—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00178	CcSEcCtD
Metoprolol—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00178	CcSEcCtD
Metoprolol—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.00178	CcSEcCtD
Metoprolol—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00177	CcSEcCtD
Metoprolol—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000173	0.00176	CcSEcCtD
Metoprolol—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000173	0.00176	CcSEcCtD
Metoprolol—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00174	CcSEcCtD
Metoprolol—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00173	CcSEcCtD
Metoprolol—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00171	CcSEcCtD
Metoprolol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00171	CcSEcCtD
Metoprolol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000168	0.0017	CcSEcCtD
Metoprolol—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.0017	CcSEcCtD
Metoprolol—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.0017	CcSEcCtD
Metoprolol—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.0017	CcSEcCtD
Metoprolol—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00169	CcSEcCtD
Metoprolol—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00169	CcSEcCtD
Metoprolol—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00168	CcSEcCtD
Metoprolol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000165	0.00167	CcSEcCtD
Metoprolol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00167	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00167	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00167	CcSEcCtD
Metoprolol—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00166	CcSEcCtD
Metoprolol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00166	CcSEcCtD
Metoprolol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.00165	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000161	0.00164	CcSEcCtD
Metoprolol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00163	CcSEcCtD
Metoprolol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00163	CcSEcCtD
Metoprolol—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.00163	CcSEcCtD
Metoprolol—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00016	0.00163	CcSEcCtD
Metoprolol—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00162	CcSEcCtD
Metoprolol—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00162	CcSEcCtD
Metoprolol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00162	CcSEcCtD
Metoprolol—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00161	CcSEcCtD
Metoprolol—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00161	CcSEcCtD
Metoprolol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00161	CcSEcCtD
Metoprolol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000158	0.00161	CcSEcCtD
Metoprolol—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000157	0.0016	CcSEcCtD
Metoprolol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000157	0.00159	CcSEcCtD
Metoprolol—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00159	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00158	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00158	CcSEcCtD
Metoprolol—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00158	CcSEcCtD
Metoprolol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00158	CcSEcCtD
Metoprolol—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00158	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00158	CcSEcCtD
Metoprolol—Pain—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00157	CcSEcCtD
Metoprolol—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00157	CcSEcCtD
Metoprolol—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00157	CcSEcCtD
Metoprolol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00157	CcSEcCtD
Metoprolol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00157	CcSEcCtD
Metoprolol—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00156	CcSEcCtD
Metoprolol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00155	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000152	0.00155	CcSEcCtD
Metoprolol—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000152	0.00155	CcSEcCtD
Metoprolol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00154	CcSEcCtD
Metoprolol—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00154	CcSEcCtD
Metoprolol—Pain—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00154	CcSEcCtD
Metoprolol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.00153	CcSEcCtD
Metoprolol—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00152	CcSEcCtD
Metoprolol—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000149	0.00152	CcSEcCtD
Metoprolol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000149	0.00152	CcSEcCtD
Metoprolol—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00151	CcSEcCtD
Metoprolol—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00151	CcSEcCtD
Metoprolol—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00151	CcSEcCtD
Metoprolol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.00151	CcSEcCtD
Metoprolol—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000148	0.0015	CcSEcCtD
Metoprolol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000148	0.0015	CcSEcCtD
Metoprolol—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.0015	CcSEcCtD
Metoprolol—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000147	0.0015	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00149	CcSEcCtD
Metoprolol—ADRB1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000147	0.0173	CbGpPWpGaD
Metoprolol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00149	CcSEcCtD
Metoprolol—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00148	CcSEcCtD
Metoprolol—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00148	CcSEcCtD
Metoprolol—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00147	CcSEcCtD
Metoprolol—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00146	CcSEcCtD
Metoprolol—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00146	CcSEcCtD
Metoprolol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00145	CcSEcCtD
Metoprolol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00145	CcSEcCtD
Metoprolol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00145	CcSEcCtD
Metoprolol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00145	CcSEcCtD
Metoprolol—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00145	CcSEcCtD
Metoprolol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000142	0.00144	CcSEcCtD
Metoprolol—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.00143	CcSEcCtD
Metoprolol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.00143	CcSEcCtD
Metoprolol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000141	0.00143	CcSEcCtD
Metoprolol—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00143	CcSEcCtD
Metoprolol—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00143	CcSEcCtD
Metoprolol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.00142	CcSEcCtD
Metoprolol—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.00142	CcSEcCtD
Metoprolol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00142	CcSEcCtD
Metoprolol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00142	CcSEcCtD
Metoprolol—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00142	CcSEcCtD
Metoprolol—ADRB1—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.0162	CbGpPWpGaD
Metoprolol—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000137	0.0014	CcSEcCtD
Metoprolol—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00139	CcSEcCtD
Metoprolol—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.016	CbGpPWpGaD
Metoprolol—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00138	CcSEcCtD
Metoprolol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00137	CcSEcCtD
Metoprolol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00137	CcSEcCtD
Metoprolol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00135	CcSEcCtD
Metoprolol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00135	CcSEcCtD
Metoprolol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000133	0.00135	CcSEcCtD
Metoprolol—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.00135	CcSEcCtD
Metoprolol—ADRB1—Endothelin Pathways—EDN1—chronic obstructive pulmonary disease	0.000132	0.0156	CbGpPWpGaD
Metoprolol—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000131	0.0154	CbGpPWpGaD
Metoprolol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00013	0.00132	CcSEcCtD
Metoprolol—Propranolol—ADRB2—chronic obstructive pulmonary disease	0.000129	0.0296	CrCbGaD
Metoprolol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00132	CcSEcCtD
Metoprolol—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00132	CcSEcCtD
Metoprolol—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000128	0.0013	CcSEcCtD
Metoprolol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.0013	CcSEcCtD
Metoprolol—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00129	CcSEcCtD
Metoprolol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00128	CcSEcCtD
Metoprolol—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00127	CcSEcCtD
Metoprolol—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.0147	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000125	0.0147	CbGpPWpGaD
Metoprolol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00125	CcSEcCtD
Metoprolol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00125	CcSEcCtD
Metoprolol—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00125	CcSEcCtD
Metoprolol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00124	CcSEcCtD
Metoprolol—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00124	CcSEcCtD
Metoprolol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00123	CcSEcCtD
Metoprolol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00122	CcSEcCtD
Metoprolol—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00012	0.0142	CbGpPWpGaD
Metoprolol—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00121	CcSEcCtD
Metoprolol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00121	CcSEcCtD
Metoprolol—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000117	0.00119	CcSEcCtD
Metoprolol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00118	CcSEcCtD
Metoprolol—ADRB1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000116	0.0137	CbGpPWpGaD
Metoprolol—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00117	CcSEcCtD
Metoprolol—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00117	CcSEcCtD
Metoprolol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00117	CcSEcCtD
Metoprolol—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.00116	CcSEcCtD
Metoprolol—Rash—Formoterol—chronic obstructive pulmonary disease	0.000114	0.00116	CcSEcCtD
Metoprolol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.00116	CcSEcCtD
Metoprolol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000114	0.00116	CcSEcCtD
Metoprolol—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00115	CcSEcCtD
Metoprolol—ADRB2—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000113	0.0134	CbGpPWpGaD
Metoprolol—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.00115	CcSEcCtD
Metoprolol—Headache—Formoterol—chronic obstructive pulmonary disease	0.000113	0.00115	CcSEcCtD
Metoprolol—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00115	CcSEcCtD
Metoprolol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00114	CcSEcCtD
Metoprolol—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000112	0.00114	CcSEcCtD
Metoprolol—Rash—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00113	CcSEcCtD
Metoprolol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00113	CcSEcCtD
Metoprolol—Propranolol—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.0254	CrCbGaD
Metoprolol—Depression—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00113	CcSEcCtD
Metoprolol—Headache—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00113	CcSEcCtD
Metoprolol—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.0128	CbGpPWpGaD
Metoprolol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.0011	CcSEcCtD
Metoprolol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00109	CcSEcCtD
Metoprolol—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.00109	CcSEcCtD
Metoprolol—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.00109	CcSEcCtD
Metoprolol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.00109	CcSEcCtD
Metoprolol—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000107	0.00109	CcSEcCtD
Metoprolol—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.00109	CcSEcCtD
Metoprolol—Propranolol—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.0245	CrCbGaD
Metoprolol—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.00108	CcSEcCtD
Metoprolol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00107	CcSEcCtD
Metoprolol—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000105	0.00107	CcSEcCtD
Metoprolol—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00105	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.000103	0.0121	CbGpPWpGaD
Metoprolol—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00103	CcSEcCtD
Metoprolol—ADRB1—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.000102	0.012	CbGpPWpGaD
Metoprolol—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.00103	CcSEcCtD
Metoprolol—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.0119	CbGpPWpGaD
Metoprolol—ADRB2—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	9.94e-05	0.0117	CbGpPWpGaD
Metoprolol—Hallucination—Prednisone—chronic obstructive pulmonary disease	9.94e-05	0.00101	CcSEcCtD
Metoprolol—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	9.87e-05	0.0116	CbGpPWpGaD
Metoprolol—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	9.82e-05	0.000998	CcSEcCtD
Metoprolol—Oedema—Prednisolone—chronic obstructive pulmonary disease	9.77e-05	0.000993	CcSEcCtD
Metoprolol—ADRB1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	9.74e-05	0.0115	CbGpPWpGaD
Metoprolol—Shock—Prednisolone—chronic obstructive pulmonary disease	9.61e-05	0.000977	CcSEcCtD
Metoprolol—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.53e-05	0.000969	CcSEcCtD
Metoprolol—ADRB2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	9.53e-05	0.0112	CbGpPWpGaD
Metoprolol—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	9.49e-05	0.0112	CbGpPWpGaD
Metoprolol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.44e-05	0.00096	CcSEcCtD
Metoprolol—Eye disorder—Prednisone—chronic obstructive pulmonary disease	9.33e-05	0.000949	CcSEcCtD
Metoprolol—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	9.28e-05	0.0109	CbGpPWpGaD
Metoprolol—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	9.07e-05	0.0107	CbGpPWpGaD
Metoprolol—Angiopathy—Prednisone—chronic obstructive pulmonary disease	9.06e-05	0.000922	CcSEcCtD
Metoprolol—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	9.02e-05	0.000917	CcSEcCtD
Metoprolol—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000907	CcSEcCtD
Metoprolol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.83e-05	0.000898	CcSEcCtD
Metoprolol—Alopecia—Prednisone—chronic obstructive pulmonary disease	8.83e-05	0.000898	CcSEcCtD
Metoprolol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	8.77e-05	0.000892	CcSEcCtD
Metoprolol—Mental disorder—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.00089	CcSEcCtD
Metoprolol—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	8.73e-05	0.0103	CbGpPWpGaD
Metoprolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	8.67e-05	0.0102	CbGpPWpGaD
Metoprolol—Pain—Prednisolone—chronic obstructive pulmonary disease	8.35e-05	0.000849	CcSEcCtD
Metoprolol—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.19e-05	0.000833	CcSEcCtD
Metoprolol—ADRB1—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	8.07e-05	0.00951	CbGpPWpGaD
Metoprolol—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.05e-05	0.000818	CcSEcCtD
Metoprolol—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	7.82e-05	0.00922	CbGpPWpGaD
Metoprolol—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.81e-05	0.000794	CcSEcCtD
Metoprolol—Syncope—Prednisone—chronic obstructive pulmonary disease	7.8e-05	0.000793	CcSEcCtD
Metoprolol—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.76e-05	0.000789	CcSEcCtD
Metoprolol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.64e-05	0.000777	CcSEcCtD
Metoprolol—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.51e-05	0.000763	CcSEcCtD
Metoprolol—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.4e-05	0.000753	CcSEcCtD
Metoprolol—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.38e-05	0.00075	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.000748	CcSEcCtD
Metoprolol—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	7.33e-05	0.00864	CbGpPWpGaD
Metoprolol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.19e-05	0.000732	CcSEcCtD
Metoprolol—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	7.19e-05	0.00848	CbGpPWpGaD
Metoprolol—Oedema—Prednisone—chronic obstructive pulmonary disease	7.1e-05	0.000722	CcSEcCtD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	7.02e-05	0.00827	CbGpPWpGaD
Metoprolol—Shock—Prednisone—chronic obstructive pulmonary disease	6.98e-05	0.00071	CcSEcCtD
Metoprolol—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.96e-05	0.000708	CcSEcCtD
Metoprolol—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.93e-05	0.000704	CcSEcCtD
Metoprolol—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.89e-05	0.000701	CcSEcCtD
Metoprolol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.86e-05	0.000698	CcSEcCtD
Metoprolol—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	6.74e-05	0.00794	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	6.64e-05	0.00783	CbGpPWpGaD
Metoprolol—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	6.52e-05	0.00769	CbGpPWpGaD
Metoprolol—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.47e-05	0.000657	CcSEcCtD
Metoprolol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.46e-05	0.000657	CcSEcCtD
Metoprolol—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.000653	CcSEcCtD
Metoprolol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000648	CcSEcCtD
Metoprolol—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.000635	CcSEcCtD
Metoprolol—Rash—Prednisolone—chronic obstructive pulmonary disease	6.16e-05	0.000626	CcSEcCtD
Metoprolol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.15e-05	0.000626	CcSEcCtD
Metoprolol—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.000622	CcSEcCtD
Metoprolol—Headache—Prednisolone—chronic obstructive pulmonary disease	6.12e-05	0.000622	CcSEcCtD
Metoprolol—Constipation—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000617	CcSEcCtD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	5.92e-05	0.00698	CbGpPWpGaD
Metoprolol—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.85e-05	0.000595	CcSEcCtD
Metoprolol—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.8e-05	0.00059	CcSEcCtD
Metoprolol—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.8e-05	0.00059	CcSEcCtD
Metoprolol—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	5.77e-05	0.0068	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	5.72e-05	0.00674	CbGpPWpGaD
Metoprolol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	5.64e-05	0.00665	CbGpPWpGaD
Metoprolol—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.64e-05	0.000573	CcSEcCtD
Metoprolol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.61e-05	0.00057	CcSEcCtD
Metoprolol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.61e-05	0.00057	CcSEcCtD
Metoprolol—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	5.56e-05	0.00656	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	5.41e-05	0.00638	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	5.38e-05	0.00634	CbGpPWpGaD
Metoprolol—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	5.3e-05	0.00625	CbGpPWpGaD
Metoprolol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.23e-05	0.000532	CcSEcCtD
Metoprolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	5.19e-05	0.00611	CbGpPWpGaD
Metoprolol—ADRB1—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	5.14e-05	0.00606	CbGpPWpGaD
Metoprolol—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	5.12e-05	0.00603	CbGpPWpGaD
Metoprolol—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000518	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	5.03e-05	0.00593	CbGpPWpGaD
Metoprolol—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.02e-05	0.000511	CcSEcCtD
Metoprolol—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	4.98e-05	0.00587	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	4.93e-05	0.00582	CbGpPWpGaD
Metoprolol—ADRB2—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	4.88e-05	0.00575	CbGpPWpGaD
Metoprolol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.86e-05	0.000494	CcSEcCtD
Metoprolol—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	4.74e-05	0.00559	CbGpPWpGaD
Metoprolol—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.69e-05	0.000477	CcSEcCtD
Metoprolol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	4.57e-05	0.00539	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	4.56e-05	0.00537	CbGpPWpGaD
Metoprolol—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.51e-05	0.000459	CcSEcCtD
Metoprolol—Rash—Prednisone—chronic obstructive pulmonary disease	4.47e-05	0.000455	CcSEcCtD
Metoprolol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.47e-05	0.000455	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	4.46e-05	0.00526	CbGpPWpGaD
Metoprolol—Headache—Prednisone—chronic obstructive pulmonary disease	4.45e-05	0.000452	CcSEcCtD
Metoprolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	4.44e-05	0.00523	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	4.38e-05	0.00517	CbGpPWpGaD
Metoprolol—Nausea—Prednisone—chronic obstructive pulmonary disease	4.22e-05	0.000429	CcSEcCtD
Metoprolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	4.2e-05	0.00495	CbGpPWpGaD
Metoprolol—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	4.19e-05	0.00494	CbGpPWpGaD
Metoprolol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.1e-05	0.00483	CbGpPWpGaD
Metoprolol—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.04e-05	0.00476	CbGpPWpGaD
Metoprolol—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	3.95e-05	0.00466	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	3.91e-05	0.0046	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	3.82e-05	0.0045	CbGpPWpGaD
Metoprolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.77e-05	0.00444	CbGpPWpGaD
Metoprolol—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.72e-05	0.00438	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	3.63e-05	0.00428	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	3.38e-05	0.00399	CbGpPWpGaD
Metoprolol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.32e-05	0.00391	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	3.23e-05	0.00381	CbGpPWpGaD
Metoprolol—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	3.22e-05	0.00379	CbGpPWpGaD
Metoprolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.05e-05	0.0036	CbGpPWpGaD
Metoprolol—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	3e-05	0.00353	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	2.97e-05	0.00351	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.92e-05	0.00344	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	2.91e-05	0.00343	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.89e-05	0.0034	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	2.86e-05	0.00337	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.69e-05	0.00317	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.66e-05	0.00313	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.54e-05	0.00299	CbGpPWpGaD
Metoprolol—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	2.52e-05	0.00297	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.45e-05	0.00289	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.44e-05	0.00287	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.43e-05	0.00286	CbGpPWpGaD
Metoprolol—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.39e-05	0.00282	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.38e-05	0.00281	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.24e-05	0.00263	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.23e-05	0.00263	CbGpPWpGaD
Metoprolol—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.2e-05	0.0026	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.19e-05	0.00258	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.19e-05	0.00258	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.14e-05	0.00252	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.09e-05	0.00246	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.05e-05	0.00242	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.04e-05	0.0024	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.02e-05	0.00239	CbGpPWpGaD
Metoprolol—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2e-05	0.00235	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.92e-05	0.00226	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.89e-05	0.00223	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.87e-05	0.00221	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.87e-05	0.0022	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.86e-05	0.0022	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.86e-05	0.00219	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.85e-05	0.00218	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	1.85e-05	0.00218	CbGpPWpGaD
Metoprolol—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.84e-05	0.00217	CbGpPWpGaD
Metoprolol—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.84e-05	0.00216	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	1.78e-05	0.00209	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.76e-05	0.00208	CbGpPWpGaD
Metoprolol—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.74e-05	0.00205	CbGpPWpGaD
Metoprolol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	1.74e-05	0.00205	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.71e-05	0.00202	CbGpPWpGaD
Metoprolol—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.69e-05	0.00199	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.68e-05	0.00198	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.68e-05	0.00198	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.67e-05	0.00197	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.64e-05	0.00194	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	1.63e-05	0.00193	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.63e-05	0.00192	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.62e-05	0.00191	CbGpPWpGaD
Metoprolol—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.6e-05	0.00189	CbGpPWpGaD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	1.54e-05	0.00181	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.53e-05	0.0018	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.52e-05	0.00179	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	1.5e-05	0.00177	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.49e-05	0.00176	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.48e-05	0.00174	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.46e-05	0.00172	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.44e-05	0.0017	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.43e-05	0.00168	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	1.42e-05	0.00167	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	1.39e-05	0.00163	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	1.38e-05	0.00163	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.31e-05	0.00154	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.3e-05	0.00154	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	1.29e-05	0.00152	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.18e-05	0.00139	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.16e-05	0.00136	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.12e-05	0.00132	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.09e-05	0.00129	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.05e-05	0.00124	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.00119	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	9.57e-06	0.00113	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.42e-06	0.00111	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.4e-06	0.00111	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.32e-06	0.0011	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.22e-06	0.00109	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.18e-06	0.00108	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	9.15e-06	0.00108	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.02e-06	0.00106	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.01e-06	0.00106	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	8.93e-06	0.00105	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.93e-06	0.00105	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.82e-06	0.00104	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.82e-06	0.00104	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.81e-06	0.00104	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.65e-06	0.00102	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.56e-06	0.00101	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.5e-06	0.001	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	8.41e-06	0.000991	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.37e-06	0.000986	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.3e-06	0.000978	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.24e-06	0.000971	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.06e-06	0.00095	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.05e-06	0.000949	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.82e-06	0.000922	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.82e-06	0.000922	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.48e-06	0.000882	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.42e-06	0.000874	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	7.42e-06	0.000874	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.32e-06	0.000863	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.12e-06	0.000839	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	6.81e-06	0.000802	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.77e-06	0.000798	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	6.67e-06	0.000787	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.59e-06	0.000777	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.45e-06	0.00076	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	6.36e-06	0.000749	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.19e-06	0.000729	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.13e-06	0.000722	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.1e-06	0.000719	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	6e-06	0.000707	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.69e-06	0.00067	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.66e-06	0.000667	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.6e-06	0.000661	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.39e-06	0.000635	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.09e-06	0.0006	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.05e-06	0.000596	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	5e-06	0.000589	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.98e-06	0.000587	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.94e-06	0.000583	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	4.94e-06	0.000582	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.88e-06	0.000575	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.82e-06	0.000568	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.62e-06	0.000545	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.6e-06	0.000543	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.6e-06	0.000542	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.59e-06	0.000541	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	4.54e-06	0.000535	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.52e-06	0.000533	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	4.51e-06	0.000531	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.49e-06	0.00053	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.42e-06	0.000521	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.4e-06	0.000518	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.33e-06	0.00051	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.27e-06	0.000504	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.15e-06	0.000489	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	4.14e-06	0.000489	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.11e-06	0.000484	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.05e-06	0.000478	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.02e-06	0.000474	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.82e-06	0.00045	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.66e-06	0.000432	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.5e-06	0.000413	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.46e-06	0.000408	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.42e-06	0.000403	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.38e-06	0.000398	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.38e-06	0.000398	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.33e-06	0.000393	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.31e-06	0.00039	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.23e-06	0.00038	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.19e-06	0.000375	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.18e-06	0.000375	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.16e-06	0.000372	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.14e-06	0.00037	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.11e-06	0.000366	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.08e-06	0.000363	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.02e-06	0.000356	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.01e-06	0.000355	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.94e-06	0.000347	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.93e-06	0.000345	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.77e-06	0.000327	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.73e-06	0.000322	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.67e-06	0.000315	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.6e-06	0.000306	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.54e-06	0.000299	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.47e-06	0.000291	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.42e-06	0.000285	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.22e-06	0.000261	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.17e-06	0.000256	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	2.05e-06	0.000242	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.04e-06	0.00024	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2e-06	0.000236	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2e-06	0.000235	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.99e-06	0.000235	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.96e-06	0.000231	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.95e-06	0.00023	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.91e-06	0.000226	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.89e-06	0.000222	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.8e-06	0.000213	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.68e-06	0.000198	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.64e-06	0.000193	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.53e-06	0.000181	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.5e-06	0.000177	CbGpPWpGaD
